Cover Image

Predictors for participation in mass-treatment and female genital schistosomiasis re-investigation, and the effect of praziquantel treatment in South African adolescents.

<h4>Objective</h4>Female Genital Schistosomiasis (FGS) causes intravaginal lesions and symptoms that could be mistaken for sexually transmitted diseases or cancer. In adults, FGS lesions [grainy sandy patches (GSP), homogenous yellow patches (HYP), abnormal blood vessels and rubbery papu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Takalani Girly Nemungadi (Author), Elisabeth Kleppa (Author), Hashini Nilushika Galappaththi-Arachchige (Author), Pavitra Pillay (Author), Svein Gunnar Gundersen (Author), Birgitte Jyding Vennervald (Author), Patricia Doris Ndhlovu (Author), Myra Taylor (Author), Saloshni Naidoo (Author), Eyrun Floerecke Kjetland (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2024-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Reproductive health problems in rural South African young women: risk behaviour and risk factors
by: Hashini Nilushika Galappaththi-Arachchige, et al.
Published: (2018)

The Accuracy of Praziquantel Dose Poles for Mass Treatment of Schistosomiasis in School Girls in KwaZulu-Natal, South Africa.
by: Marije Baan, et al.
Published: (2016)

Characteristics of Blood Vessels in Female Genital Schistosomiasis: Paving the Way for Objective Diagnostics at the Point of Care.
by: Sigve Holmen, et al.
Published: (2016)

Health professionals' knowledge about female genital schistosomiasis. A qualitative investigation in a schistosomiasis endemic area in South Africa
by: Ingvild Sommerfelt, et al.
Published: (2023)

S. haematobium as a common cause of genital morbidity in girls: a cross-sectional study of children in South Africa.
by: Ingrid Elise Amlie Hegertun, et al.
Published: (2013)

Increased vascularity in cervicovaginal mucosa with Schistosoma haematobium infection.
by: Peter Mark Jourdan, et al.
Published: (2011)

Eosinophil granule proteins ECP and EPX as markers for a potential early-stage inflammatory lesion in female genital schistosomiasis (FGS).
by: Charles Emile Ramarokoto, et al.
Published: (2014)

Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis.
by: Amaya L Bustinduy, et al.
Published: (2016)

The WHO atlas for female-genital schistosomiasis: Co-design of a practicable diagnostic guide, digital support and training.
by: Santiago Gil Martinez, et al.
Published: (2024)

The colposcopic atlas of schistosomiasis in the lower female genital tract based on studies in Malawi, Zimbabwe, Madagascar and South Africa.
by: Hanne M Norseth, et al.
Published: (2014)

Absence of lower genital tract lesions among women of reproductive age infected with Schistosoma mansoni: A cross-sectional study using a colposcope in Western Kenya.
by: Huldah C Sang, et al.
Published: (2022)

Diagnostic performance of Schistosoma real-time PCR in urine samples from Kenyan children infected with Schistosoma haematobium: day-to-day variation and follow-up after praziquantel treatment.
by: Natalie V S Vinkeles Melchers, et al.
Published: (2014)

Praziquantel treatment decreases Schistosoma mansoni genetic diversity in experimental infections.
by: Regina Coeli, et al.
Published: (2013)

Taste, a new incentive to switch to (R)-praziquantel in schistosomiasis treatment.
by: Thorsten Meyer, et al.
Published: (2009)

Performance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool children.
by: José C Sousa-Figueiredo, et al.
Published: (2012)

Resolution of praziquantel.
by: Michael Woelfle, et al.
Published: (2011)

Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial.
by: Jennifer Keiser, et al.
Published: (2014)

Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials.
by: Dimitrios K Matthaiou, et al.
Published: (2008)

Synergy of Omeprazole and Praziquantel In Vitro Treatment against Schistosoma mansoni Adult Worms.
by: Giulliana T Almeida, et al.
Published: (2015)

Toward Measuring Schistosoma Response to Praziquantel Treatment with Appropriate Descriptors of Egg Excretion.
by: Piero L Olliaro, et al.
Published: (2015)

Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial
by: Ferrari M.L.A, et al.
Published: (2003)

Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and Praziquantel.
by: Edward Yepes, et al.
Published: (2015)

Radiological evolution of porcine neurocysticercosis after combined antiparasitic treatment with praziquantel and albendazole.
by: Carla Cangalaya, et al.
Published: (2017)

Enfrentando um flagelo silencioso e negligenciado na saúde sexual e reprodutiva na África Subsaariana através do desenvolvimento de competências de treinamento para melhorar a prevenção, diagnóstico e tratamento da esquistossomose genital feminina (EGF) para trabalhadores de saúde
by: Julie Jacobson, et al.
Published: (2022)

Association between South African high-school learners’ knowledge about tuberculosis and their intention to seek healthcare
by: Saloshni Naidoo, et al.
Published: (2013)

Female genital schistosomiasis and HIV/AIDS: Reversing the neglect of girls and women.
by: Peter J Hotez, et al.
Published: (2019)

Correction: Female genital schistosomiasis and HIV/AIDS: Reversing the neglect of girls and women.
by: Peter J Hotez, et al.
Published: (2020)

Africa's 32 cents solution for HIV/AIDS.
by: Peter J Hotez, et al.
Published: (2009)

Inflammation Caused by Praziquantel Treatment Depends on the Location of the Taenia solium Cysticercus in Porcine Neurocysticercosis.
by: Carla Cangalaya, et al.
Published: (2015)

Effect of Dihydroartemisinin-Piperaquine on the Pharmacokinetics of Praziquantel for Treatment of <i>Schistosoma mansoni</i> Infection
by: Omary Mashiku Minzi, et al.
Published: (2021)

The cytotoxicity study of praziquantel enantiomers
by: Sun Q, et al.
Published: (2016)

Reinfection of farm dogs following praziquantel treatment in an endemic region of cystic echinococcosis in southeastern Iran.
by: Mehdi Borhani, et al.
Published: (2024)

Impact of Annual Praziquantel Treatment on Urogenital Schistosomiasis in a Seasonal Transmission Focus in Central Senegal.
by: Bruno Senghor, et al.
Published: (2016)

Efficacy of China-made praziquantel for treatment of Schistosomiasis haematobium in Africa: A randomized controlled trial.
by: Xin-Yao Wang, et al.
Published: (2019)

Helminth-associated systemic immune activation and HIV co-receptor expression: response to albendazole/praziquantel treatment.
by: Mkunde Chachage, et al.
Published: (2014)

Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso
by: Seydou Touré, et al.
Published: (2008)

Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya.
by: Bridget W Kimani, et al.
Published: (2018)

Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel.
by: Francisca Mutapi, et al.
Published: (2011)

Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review.
by: Charles H King, et al.
Published: (2011)

Pathological and immunological evaluation of different regimens of praziquantel treatment in a mouse model of Schistosoma mansoni infection.
by: Ulrich Membe Femoe, et al.
Published: (2022)